...
首页> 外文期刊>Journal of receptor and signal transduction research >Methodology and problems of protein-ligand docking: Case study of dirydroorotate derydrogenase, thymidine kinase, and phosphodiesterase 4
【24h】

Methodology and problems of protein-ligand docking: Case study of dirydroorotate derydrogenase, thymidine kinase, and phosphodiesterase 4

机译:蛋白质-配体对接的方法学和问题:双硬脂酸酯去氢原酶,胸苷激酶和磷酸二酯酶4的案例研究

获取原文
获取原文并翻译 | 示例
           

摘要

The docking methodology was applied to three different therapeutically interesting enzymes: human dihydroorotate dehydrogenase (DHODH), Herpes simplex virus type I thymidine kinase (HSV1 TK) and human phosphodiesterase 4 (PDE4). Programs FlexX, AutoDock and DOCK where used. The three targets represent three distinct cases. For DHODH and HSV1 TK, the binding modes of substrate and inhibitors within the active site are known, while the binding orientation of cAMP within PDE4 has been solely hypothesized. Active site of DHODH is mainly hydrophobic and the binding mode of the inhibitor brequinar was used as a template for evaluating the docking strategies. The presence of cofactors revealed to be crucial for the definition of the docking site. The HSV1 TK active site is small and polar and contains crystal water molecules and ATP, Docking of thymidine and aciclovir (ACV) within the active site was analyzed by keeping or removing water molecules. It showed the crucial role of water in predicting the binding of pyrimidines and purines. The crystal structure of PDE4 contains magnesium and zinc cations as well as catalytic water molecule but no ligand. Several docking experiments of cAMP and rolipram were performed and the results showed clear-cut dependence between the ligand orientation and the presence of metals in the active site. All three cases show specific problems of the docking methodology, depending on the character of the active site. [References: 32]
机译:对接方法已应用于三种不同的治疗性有趣的酶:人二氢乳清酸脱氢酶(DHODH),单纯疱疹病毒I型胸苷激酶(HSV1 TK)和人磷酸二酯酶4(PDE4)。在使用时对FlexX,AutoDock和DOCK进行编程。这三个目标代表三种不同的情况。对于DHODH和HSV1 TK,已知活性位点内底物和抑制剂的结合模式,而仅假设cAMP在PDE4中的结合方向。 DHODH的活性位点主要是疏水性的,抑制剂布雷奎纳的结合模式被用作评估对接策略的模板。辅因子的存在对于确定对接位点至关重要。 HSV1 TK活性位点小且极性大,包含结晶水分子和ATP,通过保留或去除水分子来分析活性位点中胸苷和阿昔洛韦(ACV)的对接。它显示了水在预测嘧啶和嘌呤结合中的关键作用。 PDE4的晶体结构包含镁和锌阳离子以及催化性水分子,但没有配体。进行了cAMP和咯利普兰对接实验,结果表明,配体取向与活性位点中金属的存在之间存在明显的依赖性。这三种情况都显示了对接方法的特定问题,具体取决于活动站点的特征。 [参考:32]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号